ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED

Otros idiomas Zhejiang Wecome Pharmaceutical Company Limited

Acciones

300878

CNE1000047P9

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 19/06/2024			Varia. Cinco días.	Varia. 1 de enero.
14,9 ^CNY	+0,13 %		-1,84 %	-41,27 %

28/04	Zhejiang Wecome Pharmaceutical Company Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
19/04	Zhejiang Wecome Pharmaceutical Company Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Zhejiang Wecome Pharmaceutical Company Limited Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	22/05
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Tranche Update on Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback Plan announced on February 7, 2024.	27/02
Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback announced on February 7, 2024, has closed with 2,739,026 shares, representing 1.89% for CNY 50 million.	27/02
Zhejiang Wecome Pharmaceutical Company Limited announces an Equity Buyback for CNY 50 million worth of its shares.	07/02
Zhejiang Wecome Pharmaceutical Company Limited authorizes a Buyback Plan.	07/02
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Certain A Shares of Zhejiang Wecome Pharmaceutical Company Limited are subject to a Lock-Up Agreement Ending on 24-AUG-2023.	24/08/23
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Zhejiang Wecome Pharma to Issue $95 Million Convertible Bonds	12/10/22
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Hangzhou Haishan Pharmaceutical Equipment Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Wecome Pharmaceutical Company Limited	18/07/22
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022	13/06/22
Zhejiang Wecome Pharmaceutical Company Limited Approved Cash Dividend for the Year 2021	07/06/22
Zhejiang Wecome Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2021	29/04/22
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zhejiang Wecome Pharmaceutical Company Limited

Acciones

300878

CNE1000047P9

Otros idiomas

Filtros